Michael Braun: The Work Is Not Finished in Sickle Cell Disease
Michael Braun, U.S. Specialty Care President at Pfizer, shared a post on LinkedIn:
“Sickle cell disease affects millions of people worldwide — and still carries the weight of inequity. For too many, the journey is defined not just by pain and crises, but by delayed diagnoses, limited access to specialized care, and treatment options that haven’t kept pace with the urgency.
On World Sickle Cell Day, I’m thinking about a community that has been asked to wait too long for progress — and what it means to truly show up for them.
For our team at Pfizer, that means continuing to advance our research and education in sickle cell disease, supporting scholarships, helping nonprofit organizations in their mission to ease the burden of travel to care, and listening closely to the people most affected.
Progress is possible, and it’s also necessary. Our work isn’t finished.
To everyone living with sickle cell, caring for someone who is, or fighting for change in this community:
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?